Development of an inactivated vaccine candidate for SARS-CoV-2

Gao, Qiang, Bao, Linlin, Mao, Haiyan, Wang, Lin, Xu, Kangwei, Yang, Minnan, Li, Yajing, Zhu, Ling, Wang, Nan, Lv, Zhe, Gao, Hong, Ge, Xiaoqin, Kan, Biao, Hu, Yaling, Liu, Jiangning, Cai, Fang, Jiang, Deyu, Yin, Yanhui, Qin, Chengfeng, Li, Jing, Gong, Xuejie, Lou, Xiuyu, Shi, Wen, Wu, Dongdong, Zhang, Hengming, Zhu, Lang, Deng, Wei, Li, Yurong, Lu, Jinxing, Li, Changgui, Wang, Xiangxi, Yin, Weidong, Zhang, Yanjun, Qin, Chuan·2020·Science

DOI 10.1126/science.abc1932

Cited by (1,435)

Items 101–200 of 1,435

Vaccines for COVID-19
John S. Tregoning, E S Brown, Hannah M. Cheeseman, Katie E. Flight, Sophie L. Higham, N-M Lemm, Benjamin F. Pierce, David C. Stirling, Ziyin Wang, Katrina M. Pollock · 2020 · Clinical & Experimental Immunology
COVID-19: Coronavirus Vaccine Development Updates
Jing Zhao, Shan Zhao, Junxian Ou, Jing Zhang, Wendong Lan, Wenyi Guan, Xiaowei Wu, Yuqian Yan, Wei Zhao, Jianguo Wu et al. · 2020 · Frontiers in Immunology
Evidence for SARS-CoV-2 Infection of Animal Hosts
Ahmed Sayed Abdel-Moneim, Elsayed M. Abdelwhab · 2020 · Pathogens
The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong, Suideng Qin, Lunzhi Dai, Zhixin Tian · 2021 · Signal Transduction and Targeted Therapy
Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles
Maolin Lu, Pradeep Devappa Uchil, Wenwei Li, Desheng Zheng, Daniel S. Terry, Jason Gorman, Wei Shi, Baoshan Zhang, Tongqing Zhou, Shilei Ding et al. · 2020 · Cell Host & Microbe
The architecture of the SARS-CoV-2 RNA genome inside virion
Changchang Cao, Zhaokui Cai, Xia Xiao, Jian Yu Rao, Juan Chen, Naijing Hu, Minnan Yang, Xiaorui Xing, Yongle Wang, Manman Li et al. · 2021 · Nature Communications
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Colin D. Funk, Craig A. Laferrière, Ali Ardakani · 2020 · Frontiers in Pharmacology
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu, Wei Xu, Shuai Xia, Chenjian Gu, Xinling Wang, Qian Wang, Jie Zhou, Yanling Wu, Xia Cai, Di Qu et al. · 2020 · Signal Transduction and Targeted Therapy
Adjuvants for Coronavirus Vaccines
Zhihui Liang, Haoru Zhu, Xin Wang, Bo Jing, Zifan Li, Xinyu Xia, Hongwu Sun, Yun Yang, Weiting Zhang, Li Shi et al. · 2020 · Frontiers in Immunology
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
Raveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, Virginia Gillespie, Florian Krammer, Adolfo García‐Sastre, Lynda Coughlan, Michael Schotsaert, Melissa B. Uccellini · 2020 · Emerging Microbes & Infections
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice
James Brett Case, Paul W. Rothlauf, Rita E. Chen, Natasha M. Kafai, Julie M. Fox, Brittany K. Smith, Swathi Shrihari, Broc T. McCune, Ian B. Harvey, Shamus P. Keeler et al. · 2020 · Cell Host & Microbe
Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection
Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre‐Bosquet, Marloes Grobben, Mathieu A. F. Claireaux, Marlon de Gast, Romain Marlin, Virginie Chesnais, Ségolène Diry et al. · 2020 · Cell
Assessing COVID-19 Vaccine Hesitancy, Confidence, and Public Engagement: A Global Social Listening Study
Zhiyuan Hou, Yixin Tong, Fanxing Du, Linyao Lu, Sihong Zhao, Kexin Yu, Simon J. Piatek, Heidi Jane Larson, Leesa K. Lin · 2021 · Journal of Medical Internet Research
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna J. Patel, Kishu Ranjan · 2021 · Biomolecules
The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET
Chuang Liu, Luiza Mendonça, Yang Yang, Yuanzhu Gao, Chenguang Shen, Jiwei Liu, Tao Ni, Bin Ju, Congcong Liu, Xian Tang et al. · 2020 · Structure
Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis
Bryan A. Johnson, Xuping Xie, Birte Kalveram, Kumari G. Lokugamage, Antonio E. Muruato, Jing Zou, Xianwen Zhang, Terry L. Juelich, Jennifer K. Smith, Lihong Zhang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People
Anna Julia Pietrobon, Franciane Mouradian Emidio Teixeira, Maria Notomi Sato · 2020 · Frontiers in Immunology
A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV‑2 in Mice
Abigail E. Powell, Kaiming Zhang, Mrinmoy Sanyal, Shaogeng Tang, Payton A. B. Weidenbacher, Shanshan Li, Tho D. Pham, John E. Pak, Wah Chiu, Peter S. Kim · 2021 · ACS Central Science
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
Ku, Zhiqiang, Xie, Xuping, Davidson, Edgar, Ye, Xiaohua, Su, Hang, Menachery, Vineet D., Li, Yize, Yuan, Zihao, Zhang, Xianwen, Muruato, Antonio E. et al. · 2021 · Nature Communications
Ocular Adverse Events After COVID-19 Vaccination
Xin Le Ng, Bjorn Kaijun Betzler, Ilaria Testi, Su Ling Ho, Melissa Chih-Hui Tien, Wei Kiong Ngo, Manfred Zierhut, Soon-Phaik Chee, Vishali Gupta, Carlos Eduardo Pavesio et al. · 2021 · Ocular Immunology and Inflammation
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
Hirofumi Ohashi, Koichi Watashi, Wakana Saso, Kaho Shionoya, Shoya Iwanami, Takatsugu Hirokawa, Tsuyoshi Shirai, Shigehiko Kanaya, Yusuke Ito, Kwang Su Kim et al. · 2021 · iScience
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen, Neeltje, Lambe, Teresa, Spencer, Alexandra, Belij-Rammerstorfer, Sandra, Purushotham, Jyothi N., Port, Julia R., Avanzato, Victoria, Bushmaker, Trenton, Flaxman, Amy, Ulaszewska, Marta et al. · 2020
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
Kang Wang, Zijing Jia, Linilin Bao, Lei Wang, Lei Cao, Hang Chi, Yaling Hu, Qianqian Li, Yunjiao Zhou, Yinan Jiang et al. · 2022 · Nature
An overview of current COVID-19 vaccine platforms
Abdou Nagy, B. Alhatlani · 2021 · Computational and Structural Biotechnology Journal
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
Lorena Sánchez-Felipe, Thomas Vercruysse, Sapna Sharma, Ji Ma, Viktor Lemmens, Dominique Van Looveren, Mahadesh Prasad Arkalagud Javarappa, Robbert Boudewijns, Bert Malengier‐Devlies, Laurens Liesenborghs et al. · 2020 · Nature
Phylogenomic analyses provide insights into primate evolution
Yong Shao, Long Zhou, Fang Li, Lan Zhao, Bao-Lin Zhang, Feng Shao, Jiawei Chen, Chunyan Chen, Xupeng Bi, Xiao-Lin Zhuang et al. · 2023 · Science
Nanotechnology Responses to COVID‐19
Eduardo Ruiz‐Hitzky, Margarita Darder, Bernd Wicklein, Cristina Ruiz‐García, Raquel Martín‐Sampedro, Gustavo del Real, Pîlar Aranda · 2020 · Advanced Healthcare Materials
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies
Maria Trovato, Rossella Sartorius, Luciana D’Apice, Roberta Manco, Piergiuseppe De Berardinis · 2020 · Frontiers in Immunology
Learning from the past: development of safe and effective COVID-19 vaccines
Shan Su, Lanying Du, Shibo Jiang · 2020 · Nature Reviews Microbiology
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed Saeed Nassar, Abdullah Awad Alshehri, Meshal K. Alnefaie, Fahad A. Almughem, Bayan Y. Alshehri, Abdullah O. Alawad, Essam A. Tawfik · 2023 · Pharmaceutics
Immunity to SARS‐CoV‐2 induced by infection or vaccination
Xaquín Castro Dopico, Sebastian Ols, Karin Loré, Gunilla B. Karlsson Hedestam · 2021 · Journal of Internal Medicine
Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
Yunlong Cao, Fanchong Jian, Zhiying Zhang, Ayijiang Yisimayi, Xiaohua Hao, Linlin Bao, Fei Yuan, Yuanling Yu, Shuo Du, Jing Wang et al. · 2022 · Cell Reports
Transfer learning with fine-tuned deep CNN ResNet50 model for classifying COVID-19 from chest X-ray images
Md. Belal Hossain, Shahriar Iqbal, Md. Monirul Islam, Md. Nasim Akhtar, Iqbal Hasan Sarker · 2022 · Informatics in Medicine Unlocked
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine
Yasunori Watanabe, Luiza Mendonça, Elizabeth R. Allen, Andrew Howe, Mercede Lee, Joel D. Allen, Himanshi Chawla, David Pulido, Francesca R. Donnellan, H. Dele Davies et al. · 2021 · ACS Central Science
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Joshua G. Liang, Danmei Su, Tian‐Zhang Song, Yilan Zeng, Weijin Huang, Jinhua Wu, Rong Xu, Peiwen Luo, Xiaofang Yang, Xiaodong Zhang et al. · 2021 · Nature Communications
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile
Susan M. Bueno, Katia Abarca V, Pablo A. González, Nicolás M. S. Gálvez, Jorge A. Soto, Luisa Fernanda Duarte, Bárbara M. Schultz, Gaspar A. Pacheco, Liliana A González, Yaneisi Vázquez et al. · 2021 · Clinical Infectious Diseases
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, Zhanlong He, Yanyan Li, Fengmei Yang, Xin Zhao, Youchun Wang, Weijin Huang, Meng Qin et al. · 2023 · Nature
New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
Gangqiang Guo, Lele Ye, Kan Pan, Yu Zheng Chen, Dong Xing, Kejing Yan, Zhiyuan Chen, Ning Ding, Wenshu Li, Hong Huang et al. · 2020 · Frontiers in Cell and Developmental Biology
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
Subodh Kumar Samrat, Anil Mathew Tharappel, Zhong Li, Hongmin Li · 2020 · Virus Research
Current Prevention of COVID-19: Natural Products and Herbal Medicine
Junqing Huang, Gabriel Tao, Jingwen Liu, Junming Cai, Zhongyu Huang, Jiaxu Chen · 2020 · Frontiers in Pharmacology
COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation
Mazin Adnan Barry, Mohamad-Hani A. Temsah, Abdullah Alhuzaimi, Nurah Alamro, Ayman A. Al-Eyadhy, Fadi Aljamaan, Basema Ahmad Saddik, Ali A. N. Alhaboob, Fahad Alsohime, Khalid Abdulaziz Alhasan et al. · 2021 · PLoS ONE
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia
Eddy Fadlyana, Kusnandi Rusmil, Rodman Tarigan, Andri Reza Rahmadi, Susantina Prodjosoewojo, Yulia Sofiatin, Citra Vravita Khrisna, Rini Mulia Sari, Lilis Setyaningsih, Fikrianti Surachman et al. · 2021 · Vaccine
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Jalen Singh, Pranav Pandit, Andrew G. McArthur, Arinjay Banerjee, Karen Louise Mossman · 2021 · Virology Journal
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
Ahmed O. Hassan, Friederike Feldmann, Haiyan Zhao, David T. Curiel, Atsushi Okumura, Tsing-Lee Tang-Huau, James Brett Case, Kimberly D. Meade-White, Julie A. Callison, Rita E. Chen et al. · 2021 · Cell Reports Medicine
Acute Respiratory Distress in Aged, SARS-CoV-2–Infected African Green Monkeys but Not Rhesus Macaques
Robert V. Blair, Monica Vaccari, Lara A. Doyle‐Meyers, Chad J. Roy, Kasi Russell‐Lodrigue, Marissa D. Fahlberg, Chris J. Monjure, Brandon J. Beddingfield, Kenneth S. Plante, Jessica A. Plante et al. · 2020 · American Journal Of Pathology
Efforts at COVID-19 Vaccine Development: Challenges and Successes
Azizul Haque, Anudeep B. Pant · 2020 · Vaccines
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
Ku, Min-Wen, Bourgine, Maryline, Authié, Pierre, Lopez, Jodie, Nemirov, Kirill, Moncoq, Fanny, Noirat, Amandine, Vesin, Benjamin, Nevo, Fabien, Blanc, Catherine et al. · 2021 · Cell Host & Microbe
Propagation, Inactivation, and Safety Testing of SARS-CoV-2
Alexander S. Jureka, Jesus A. Silvas, Christopher F. Basler · 2020 · Viruses
Uveitis and Other Ocular Complications Following COVID-19 Vaccination
Elena Bolletta, Danilo Iannetta, Valentina Mastrofilippo, Luca De Simone, Fabrizio Gozzi, Stefania Croci, Martina Bonacini, Lucia Belloni, Alessandro Zerbini, Chantal Adani et al. · 2021 · Journal of Clinical Medicine
Current advances in the development of SARS-CoV-2 vaccines
Awadasseid, Annoor, Wu, Yanling, Tanaka, Yoshimasa, Zhang, Wen · 2021 · International Journal of Biological Sciences
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity
Yang, Ren, Deng, Yao, Huang, Baoying, Huang, Lei, Lin, Ang, Li, Yuhua, Wang, Wenling, Liu, Jingjing, Lu, Shuaiyao, Zhan, Zhenzhen et al. · 2021 · Signal Transduction and Targeted Therapy
The scientific and ethical feasibility of immunity passports
Rebecca C. H. Brown, Dominic F. Kelly, Dominic J. C. Wilkinson, Julian Savulescu · 2020 · The Lancet Infectious Diseases
COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology
Hyun Jee Han, Chinekwu Sherridan Nwagwu, Obumneme Benneth Anyim, Chinedu Ekweremadu, San Kim · 2020 · International Immunopharmacology
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection
J. Dan, José Mateus, Y. Kato, K. Hastie, E. Yu, Caterina E. Faliti, A. Grifoni, S. Ramirez, Sonya Haupt, April Frazier et al. · 2020 · bioRxiv
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
Jean‐Michel Sallenave, Loïc Guillot · 2020 · Frontiers in Immunology
Physicochemical properties of SARS‐CoV‐2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control
Christin Scheller, Finja Krebs, Robert Minkner, Isabel Astner, María Gil‐Moles, Hermann Wätzig · 2020 · Electrophoresis
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
Ivan Mercurio, Vincenzo Tragni, Francesco Busto, Anna Grassi, Ciro Leonardo Pierri · 2020 · Cellular and Molecular Life Sciences
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
Cyrielle E. Fougeroux, Louise Goksøyr, Manja Idorn, Vladislav Soroka, Sebenzile K. Myeni, Robert Dagil, Christoph Mikkel Janitzek, Max Søgaard, Kara-Lee Aves, Emma Wenzel Horsted et al. · 2021 · Nature Communications
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
Joyce K. Hwang, Tian Zhang, Andrew Zhuang Wang, Zihai Li · 2021 · Journal of Hematology & Oncology
COVID-19: Mechanisms of Vaccination and Immunity
Daniel E. Speiser, Martin F. Bachmann · 2020 · Vaccines
SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, Pourya Gholizadeh, Mohammad Asgharzadeh, Khudaverdi Ganbarov, Şükran Köse, Mehdi Yousefi, Hossein Samadi Kafil · 2021 · International Journal of Biological Macromolecules
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease
Wang, Pengfei, Liu, Lihong, Nair, Manoj S., Yin, Michael T., Luo, Yang, Wang, Qian, Yuan, Ting, Mori, Kanako, Solis, Axel Guzman, Yamashita, Masahiro et al. · 2020 · Emerging Microbes & Infections
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
Rudra P. Saha, Ashish Ranjan Sharma, Manoj Kumar Singh, Saikat Samanta, Swarnav Bhakta, Snehasish Mandal, Manojit Bhattacharya, Sang Soo Lee, Chiranjib Chakraborty · 2020 · Frontiers in Pharmacology
Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
Yujing Fan, Kwok‐Hung Chan, Ivan Fan‐Ngai Hung · 2021 · Vaccines
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
Weina Sun, Sarah R. Leist, Stephen McCroskery, Yonghong Liu, Stefan Slamanig, Justine Oliva, Fatima Amanat, Alexandra Schäfer, Kenneth H. Dinnon, Adolfo García‐Sastre et al. · 2020 · EBioMedicine
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
Linling He, Xiaohe Lin, Ying Wang, Ciril Abraham, Cindy Sou, Timothy Ngo, Yi Zhang, Ian A. Wilson, Jiang Zhu · 2021 · Science Advances
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2
Alex Renn, Ying Fu, Xin Hu, Matthew D. Hall, Anton M. Simeonov · 2020 · Trends in Pharmacological Sciences
Approaches and Challenges in SARS-CoV-2 Vaccine Development
Dagotto, Gabriel, Yu, Jingyou, Barouch, Dan H. · 2020 · Cell Host & Microbe
Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?
Mattia Tiboni, Luca Casettari, Lisbeth Illum · 2021 · International Journal of Pharmaceutics
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Shitu Mekonnen, Abtie Abebaw, Melese Getachew, Tengchuan Jin · 2021 · Seminars in Immunology
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
Qian He, Qunying Mao, Jialu Zhang, Lianlian Bian, Fan Gao, Junzhi Wang, Miao Xu, Zhenglun Liang · 2021 · Frontiers in Immunology
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Cielo García Montero, Oscar Fraile‐Μartinez, Coral Bravo, Diego Torres‐Carranza, Lara Sánchez‐Trujillo, Ana Maria Gomez-Lahoz, Luis G. Guijarro, Natalio García‐Honduvilla, Ángel Asúnsolo, Julia Buján et al. · 2021 · Vaccines
Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
Hsin‐I Shih, Chi-Jung Wu, Yi‐Fang Tu, Chia‐Yu Chi · 2020 · Biomedical Journal
The continued advance of vaccine adjuvants – ‘we can work it out’
Derek T. O’Hagan, Rushit N. Lodaya, Giuseppe Lofano · 2020 · Seminars in Immunology
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Zezhong Liu, Jie Zhou, Wei Xu, Wei Deng, Yanqun Wang, Meiyu Wang, Qian Wang, Ming Kun Hsieh, Jingming Dong, Xinling Wang et al. · 2022 · Cell Research
Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models
Lena Mautner, Mona Hoyos, Alexandra Dangel, Carola Berger, Anja Ehrhardt, Armin E. Baiker · 2022 · Virology Journal
Advances in Infectious Disease Vaccine Adjuvants
Jingyi Fan, Shengbin Jin, Lachlan Gilmartin, István Tóth, Waleed M. Hussein, Rachel J. Stephenson · 2022 · Vaccines
An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
Varghese Edwin Hillary, Stanislaus Antony Ceasar · 2023 · Heliyon
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.
Jennifer M. Dan, José Mateus, Yu Kato, Kathryn M. Hastie, Esther Dawen Yu, Caterina Elisa Faliti, Alba Grifoni, Sydney I. Ramirez, Sonya Haupt, April Frazier et al. · 2020 · eScholarship (California Digital Library)
Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines
Wagner Gouvêa dos Santos · 2021 · Biomedicine & Pharmacotherapy
Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans
Per Johan Klasse, Douglas F. Nixon, John P. Moore · 2021 · Science Advances
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
Pragya Dhruv Yadav, Raches Ella, Sanjay Kumar, Dilip Patil, Sreelekshmy Mohandas, Anita M. Shete, Krishna Mohan Vadrevu, Gaurav Bhati, Gajanan N. Sapkal, Himanshu Kaushal et al. · 2021 · Nature Communications
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines
Peter Jay Hotez, María Elena Bottazzi · 2021 · Annual Review of Medicine
Recombinant vaccines for COVID-19
Yadav, Tushar, Srivastava, Nishant, Mishra, Gourav, Dhama, Kuldeep, Kumar, Swatantra, Puri, Bipin, Saxena, Shailendra K · 2020 · Human Vaccines & Immunotherapeutics
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
Rajat Kumar Mudgal, Sanketkumar Nehul, Shailly Tomar · 2020 · Human Vaccines & Immunotherapeutics
Development of vaccines and antivirals for combating viral pandemics
Norbert Pardi, Drew Weissman · 2020 · Nature Biomedical Engineering
The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world
Hannah Sharpe, Ciarán Gilbride, Elizabeth R. Allen, Sandra Belij‐Rammerstorfer, Cameron Bissett, Katie Ewer, Teresa Lambe · 2020 · Immunology
A COVID-19 Vaccine: Big Strides Come with Big Challenges
Juanita Mellet, Michael Sean Pepper · 2021 · Vaccines
Antibody-dependent enhancement of coronavirus
Jieqi Wen, Yifan Cheng, Rongsong Ling, Yarong Dai, Boxuan Huang, Wenjie Huang, Siyan Zhang, Yi-Zhou Jiang · 2020 · International Journal of Infectious Diseases
The immunology of SARS-CoV-2 infections and vaccines
Lilit Grigoryan, Bali Pulendran · 2020 · Seminars in Immunology
COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice
Juan García‐Arriaza, Urtzi Garaigorta, Patricia Pérez, Adrián Lázaro-Frías, Carmen Zamora, Pablo Gastaminza, Carlos del Fresno, José M. Casasnovas, Carlos Óscar S. Sorzano, David Sancho et al. · 2021 · Journal of Virology
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, Yalda Yazdani, Omid Gholizadeh, Raheleh Tabatabaie, Hamed Afkhami, Fatemeh Davodabadi, Alireza Khanalipour farkhad, Daryoush Pahlevan et al. · 2022 · Journal of Nanobiotechnology
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
Shen Wang, Wujian Li, Zhenshan Wang, Wanying Yang, Entao Li, Xianzhu Xia, Feihu Yan, Sandra Chiu · 2024 · Signal Transduction and Targeted Therapy
Drug Discovery Strategies for SARS-CoV-2
Zeenat A. Shyr, Kirill Gorshkov, Catherine Z. Chen, Wei Zheng · 2020 · Journal of Pharmacology and Experimental Therapeutics
Nanocarrier vaccines for SARS-CoV-2
Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, Preet Amol Singh, Ashish Baldi, Neha Bajwa, Raj Kumar et al. · 2021 · Advanced Drug Delivery Reviews
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
Takehiro Ura, Akio Yamashita, Nobuhisa Mizuki, Kenji Okuda, Masaru Shimada · 2020 · Vaccine
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
Katie L. Flanagan, Emma Best, Nigel W. Crawford, Michelle Giles, Archana Koirala, Kristine K. Macartney, Fiona Mary Russell, Benjamin W. Teh, Sophie Chien-Hui Wen · 2020 · Frontiers in Immunology
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
Jeroen B. K. Pollet, Wen‐Hsiang Chen, Leroy Versteeg, Brian P. Keegan, Bin Zhan, Junfei Wei, Zhuyun Liu, Jungsoon Lee, Rahki Kundu, Rakesh Adhikari et al. · 2021 · Human Vaccines & Immunotherapeutics
Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases
Seyed Davoud Jazayeri, Hui Xuan Lim, Kamyar Shameli, Swee Keong Yeap, Chit Laa Poh · 2021 · Frontiers in Pharmacology
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
Weina Sun, Stephen McCroskery, Wen‐Chun Liu, Sarah R. Leist, Yonghong Liu, Randy A. Albrecht, Stefan Slamanig, Justine Oliva, Fatima Amanat, Alexandra Schäfer et al. · 2020 · Vaccines